Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Product containing ergotamine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Oral phenobarbital |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Product containing belladonna |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Psychotherapeutic agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Naturally occurring alkaloid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenobarbital (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ergotamine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ergotamine tartrate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Barbiturate antiepileptic |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Belladonna (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Analgesic (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Psychotherapeutic agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Has manufactured dose form |
Modified-release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Product containing ergotamine tartrate in oral dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Product containing belladonna in oral dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Is a |
Phenobarbital-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Belladonna alkaloids - chemical (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|